| Beau Lee, FNP-C | |
|
2900 N Burton St, Boise, ID 83704-5314 | |
| (208) 818-3459 | |
| Not Available |
| Full Name | Beau Lee |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 2900 N Burton St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013522275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 63085 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Beau Lee, FNP-C 2900 N Burton St, Boise, ID 83704-5314 Ph: (208) 818-3459 | Beau Lee, FNP-C 2900 N Burton St, Boise, ID 83704-5314 Ph: (208) 818-3459 |
News Archive
Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.
Cyprotex PLC, the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox(R). Supporting the new service is an additional 90 square metres of laboratory space at Cyprotex's Macclesfield, UK facility housing the latest technology in multi-parametric automated fluorescent imaging and cellular analysis. This gives Cyprotex's Macclesfield site the same in vitro toxicology capabilities as those of Apredica (Watertown, MA, USA), which Cyprotex acquired on 6 August 2010.
With a pair of new National Institutes of Health grants totaling nearly $3 million, Indiana University clinical psychologist Cara Lewis will tackle two major issues in the effort to bring evidence-based mental health treatment into community mental health centers.
Neurologist Benjamin Brooks, who directs the MDA ALS Center at the University of Wisconsin-Madison, presented results of a trial of tamoxifen, a drug approved for the treatment of breast cancer, at a meeting of the American Academy of Neurology in April. The trial was supported in part by MDA.
› Verified 7 days ago
Nora M Suarez, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Dr. Nancy Jane L'heureux, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6259 W Emerald St, Boise, ID 83704 Phone: 208-489-1900 Fax: 208-375-5286 | |
Jennifer Woodburn, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-5015 | |
Carl Ciplinski, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10583 W Lake Hazel Rd, Boise, ID 83709 Phone: 208-302-5950 | |
Kathryn Laura Cnossen, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8000 S Federal Way, Boise, ID 83716 Phone: 208-368-2109 | |
Mrs. Chelsea Rose Wallace, RN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9976 W Emerald St, Boise, ID 83704 Phone: 208-229-3742 | |
Natasha Michele King-anderson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 707 N Armstrong Pl, Boise, ID 83704 Phone: 208-375-5211 |